MHCI requires MEF2 transcription factors to negatively regulate synapse density during development and in disease.
about
Common Genetic Variants Found in HLA and KIR Immune Genes in Autism Spectrum DisorderMaternal immune activation: Implications for neuropsychiatric disorders.Maternal Immune Activation Causes Behavioral Impairments and Altered Cerebellar Cytokine and Synaptic Protein ExpressionInteractions of innate and adaptive immunity in brain development and function.Maternal complement C1q and increased odds for psychosis in adult offspring.Alteration of imprinted Dlk1-Dio3 miRNA cluster expression in the entorhinal cortex induced by maternal immune activation and adolescent cannabinoid exposure.Epigenetics of autism-related impairment: copy number variation and maternal infectionMajor histocompatibility complex I in brain development and schizophreniaMHC class I limits hippocampal synapse density by inhibiting neuronal insulin receptor signalingDevelopmental Sculpting of Intracortical Circuits by MHC Class I H2-Db and H2-Kb.Expression and alternative splicing of classical and nonclassical MHCI genes in the hippocampus and neuromuscular junction.Impaired synaptic development in a maternal immune activation mouse model of neurodevelopmental disordersMaternal immune activation and abnormal brain development across CNS disorders.Neuronal MHC-I expression and its implications in synaptic function, axonal regeneration and Parkinson's and other brain diseasesImmune mediators in the brain and peripheral tissues in autism spectrum disorder.Genetic architecture, epigenetic influence and environment exposure in the pathogenesis of Autism.Exposure to genocide and the risk of schizophrenia: a population-based study.Nucleocytoplasmic Shuttling of Histone Deacetylase 9 Controls Activity-Dependent Thalamocortical Axon BranchingEarly-life seizures alter synaptic calcium-permeable AMPA receptor function and plasticity.Distinct stages of synapse elimination are induced by burst firing of CA1 neurons and differentially require MEF2A/DExperience-Dependent and Differential Regulation of Local and Long-Range Excitatory Neocortical Circuits by Postsynaptic Mef2c.IGF-1 deficiency causes atrophic changes associated with upregulation of VGluT1 and downregulation of MEF2 transcription factors in the mouse cochlear nuclei.MEF2 signaling and human diseases.Tumour necrosis factor-mediated homeostatic synaptic plasticity in behavioural models: testing a role in maternal immune activation.MHC class I in dopaminergic neurons suppresses relapse to reward seeking.
P2860
Q28066081-4CC9732C-721A-4E73-AA0B-7749E4CB121CQ30248401-22CA60F6-64A1-4284-9E88-C3241C75765DQ30355368-059D9959-84EC-4CF1-9F83-4B2FFE5785D3Q30357060-873CDF39-A580-49AB-9046-D070323AA628Q34255627-863F5B5E-0163-4C57-98E7-40E771F74D94Q34370550-77076962-791A-4977-A73C-D063CE91D623Q35054571-774AD452-75CA-4DA4-827C-457B3E3E01A3Q35163148-65A1DE83-A878-48FE-B9A2-E6AB4C21813EQ35744568-1B958ABF-853F-492B-BFBF-6D3D1644AF9BQ36672537-43F8B487-5DFC-42B6-B7DB-C1A76BE9F20CQ36767935-6D47CCF1-A63A-4CDF-933D-26F95E164843Q37114691-2D357B10-EBC0-47F0-B2CA-DF9C5BBAD7D6Q38259759-BC531B28-D240-4F43-A67C-A42D8A9E9CFAQ38263500-F52F1E7E-E5F8-4FC3-8ADC-7A42A3EC1CBEQ38550206-2C72753C-95FC-4CA2-BC5D-FE657198AC7FQ38613638-D0AF7675-72AF-42B1-BE4B-4869DA721D5FQ40260923-190A9387-734D-4AC6-8CB7-2B0300DC2ABAQ41075517-E78DBBAC-00C4-422F-94BA-3AADE91C08BAQ41653639-906AE05B-7821-43E8-B6B7-E59E6169F8B7Q41691925-AC0FB62E-6768-4091-9B4A-FD3197871A90Q47132310-7047A612-ADED-49BD-A826-20CF105148FCQ48462977-28463AB1-2646-48F4-8542-ACB23B02104BQ49735398-DB5CDA26-E4EC-484C-A444-25AC051DC870Q50461350-93F2696F-B1FF-4CFC-932A-3ECAEF210638Q51739487-3A08EA6F-7D45-450F-AA94-8053E3B043F3
P2860
MHCI requires MEF2 transcription factors to negatively regulate synapse density during development and in disease.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on August 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
MHCI requires MEF2 transcripti ...... ng development and in disease.
@en
MHCI requires MEF2 transcripti ...... ng development and in disease.
@nl
type
label
MHCI requires MEF2 transcripti ...... ng development and in disease.
@en
MHCI requires MEF2 transcripti ...... ng development and in disease.
@nl
prefLabel
MHCI requires MEF2 transcripti ...... ng development and in disease.
@en
MHCI requires MEF2 transcripti ...... ng development and in disease.
@nl
P2093
P2860
P1476
MHCI requires MEF2 transcripti ...... ng development and in disease.
@en
P2093
A Kimberley McAllister
Bradford M Elmer
Myka L Estes
Stephanie L Barrow
P2860
P304
13791-13804
P356
10.1523/JNEUROSCI.2366-13.2013
P407
P577
2013-08-01T00:00:00Z